Navigation Links
Cephalon Announces Strong Third Quarter Financial Results
Date:11/8/2007

(1,881) 15,761

Other assets (28,552) (43,731)

Accounts payable and

accrued expenses 380,776 (45,820)

Other liabilities 49,465 (13,580)

Net cash provided by

operating activities 274,321 251,190

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of property and

equipment (70,887) (97,122)

Acquisition of intangible assets (99,152) (115,000)

Proceeds from sale of investment 12,291 -

Sales and (purchases) of

available-for-sale investments, net (43,186) 242,660

Net cash provided by (used for)

investing activities (200,934) 30,538

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from exercises of

common stock options 74,375 112,794

Windfall tax benefits from

stock-based compensation 9,934 21,912

Acquisition of treasury stock (128) (433)

Payments on and retirements of long-term

debt (2,902) (2,528)

Net cash provided by financing activities 81,279 131,745

EFFECT OF EXCHANGE RATE CHANGES ON

CASH AND CASH EQUIVALENTS 10,804 11,830

NET INCREASE IN CASH AND CASH EQUIVALENTS 165,470 425,303

CASH AND CASH EQUIVALENTS, BEGINNING

OF PERIOD 496,512 205,060

CASH AND CASH EQUIVALENTS, END OF PERIOD $661,982 $630,363

CEPHALON, INC. AND SUBSIDIARIES

Reconciliation of Proje
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
9. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
10. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
11. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 The new ... Spain , available today on PharmaBoardroom.com for ... Eurozone crisis that rocked the Spanish economy in 2009, and ... pharma community has remained pragmatic in times of trouble. ... still the fifth biggest European market, and the general conditions ...
(Date:9/18/2014)... A novel robotic system that can operate ... being tested as part of a biomedical research partnership ... the aim of determining if the robot, in conjunction ... faster, more accurate, less costly, and less discomforting for ... to deliver prostate cancer therapies with greater precision. , ...
(Date:9/18/2014)... , Sept. 18, 2014 Research and ... "Global and Chinese Stem Cell Industry Report, 2014-2017" ... are undifferentiated biological cells that can differentiate into specialized ... stem cells. Stem cell therapy can be applied to ... system disease), nervous system diseases, damage or lesion of ...
(Date:9/18/2014)... 2014  U.S. biotech company Kultevat has ... for technology developed by the Donald Danforth Plant ... including for applications in production of natural rubber in ... was developed under the direction of Roger Beachy ... president of the Danforth Plant Science Center, and is ...
Breaking Biology Technology:PharmaBoardroom Releases New Spain Pharmaceuticals Report 2PharmaBoardroom Releases New Spain Pharmaceuticals Report 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Global and Chinese Stem Cell Industry Report, 2014-2017 2Global and Chinese Stem Cell Industry Report, 2014-2017 3Kultevat obtains license of gene switch technology 2
... male flies of a serious agricultural pest, the medfly, have ... still embryos. Researchers writing in the open access journal ... when released into a wild population, could out-compete the normal ... stillborn protecting important crops. , Ernst A. Wimmer from ...
... GPRO ) announced today that the Company ... results on Tuesday, February 17, 2009 at,approximately 4:00 p.m. ... conference call at 4:30 p.m. ET. Hank Nordhoff, chairman ... finance, and,chief financial officer, will host the call. , ...
... 26 BioLife Solutions, Inc.,(OTC Bulletin Board: ... proprietary,GMP hypothermic storage and cryopreservation media products ... launch of its new quarterly,newsletter BioPreservation Today, ... protocols and processes, to maximize the yield ...
Cached Biology Technology:Gene-engineered flies are pest solution 2Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2008 Earnings Conference Call 2BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter 2BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter 3
(Date:9/18/2014)... 18, 2014 New research into the Crimean-Congo hemorrhagic ... severe hemorrhagic disease in humans similar to that caused ... CCHFV infection. This discovery has the potential to lead ... , The research, reported in a paper ... and conducted by scientists at the Texas Biomedical Research ...
(Date:9/18/2014)... times it,s demonstrated, it,s still hard to envision ... by using a signaling system called "quorum sensing," ... suit their population. In short, some bacteria "know" ... accordingly. , Once the population of quorum-sensing bacteria ... to pathogenic, or from unhelpful to helpful. The ...
(Date:9/18/2014)... built the first smartphone app that automatically reveals ... In other words, your smartphone knows your state ... and how that affects you. , The StudentLife ... loneliness to their academic performance, also may be ... to monitor mental health, trigger intervention and improve ...
Breaking Biology News(10 mins):Research milestone in CCHF virus could help identify new treatments 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 2Researchers study vital 'on/off switches' that control when bacteria turn deadly 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4
... international consortium of researchers led by Universitat Autnoma de ... studies the clinical impact of the mutations. , The ... and world distribution of some of the most frequent ... thousands of years ago and later migrated to America. ...
... A pathway whereby bacteria communicate with each other has ... Jerusalem. The discovery has important implications for efforts to ... body. Bacteria are known to communicate in nature ... molecules, said Prof. Sigal Ben-Yehuda of the Institute for ...
... device may help clinicians improve a promising cancer therapy ... such diseases as metastatic melanoma, non-Hodgkin,s lymphoma, chronic lymphocytic ... T cell transfer, has shown encouraging results in clinical ... T cells from a cancer patient, multiplying them in ...
Cached Biology News:New advances in genetic studies of Fanconi anemia patients 2Researchers predict age of T cells to improve cancer treatment 2Researchers predict age of T cells to improve cancer treatment 3
Request Info...
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: